Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Gene expression profiling vs. clinical guidelines for cancer therapy compared
September 29th, 2005
Gene expression profiling vs. clinical guidelines for breast cancer therapy were compared in a recent model. "Gene expression profiling has been proposed as an alternative to clinical guidelines to identify high-risk patients for adjuvant chemotherapy," scientists in the United States report. "However, the outcomes associated with gene expression profiling are not clear, and guidelines for the appropriate use of genomic technologies have not been established." N. Oestreicher and colleagues "developed a decision analytic model to evaluate the incremental cost and quality-adjusted life years of gene expression profiling versus NIH clinical guidelines in a hypothetical...
Source: Women's Health Weekly (2005-09-29)
|
